Australia's most trusted
source of pharma news
Wednesday, 15 April 2026
Posted 3 June 2021 PM
Organon officially launches today with its Australian team ready for business as the only Big Pharma with a clear and dedicated focus on women's health.
The new company, a spin-off from MSD, aims to take ownership of the women's health space with products that support reproductive health as well as everyday health needs and conditions that disproportionately affect women.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.